FOLLOW US

America April 9, 2025 4 mins read

Jazz to Pay $145M in Antitrust Settlement

America ı By Rihem Akkouche

0 Comments

jazz pharmaceuticals $145m settlement

In a high-stakes twist in the pharmaceutical legal arena, Jazz Pharmaceuticals has agreed to shell out a staggering $145 million to settle claims that it orchestrated an anticompetitive scheme with rival Hikma Pharmaceuticals to delay the launch of cheaper generic versions of its lucrative narcolepsy drug, Xyrem.

The settlement, disclosed Tuesday in a U.S. Securities and Exchange Commission Form 8-K, marks a dramatic turning point in long-running multidistrict litigation that alleged Jazz used “pay-for-delay” tactics to freeze competitors out of the market — a strategy critics liken to keeping a velvet rope around a monopoly.

The Deal: A $145M Exit from a Legal Quagmire

Jazz revealed that it reached a preliminary settlement agreement with a proposed class of indirect Xyrem purchasers — entities that either paid for or reimbursed costs of the drug — in select states. The deal would cover all claims against Jazz concerning its past patent litigation settlements with generic drugmakers.

The pharmaceutical giant, based in Ireland, maintains its denial of any wrongdoing, and the settlement is still subject to court approval.

The Allegations: Reverse Payments and Market Blockades

At the heart of the litigation were claims that Jazz entered into reverse payment agreements — effectively, cash incentives to delay competition — with Hikma Pharmaceuticals, the first company to file for approval to sell a generic version of Xyrem. Similar deals with later filers were also alleged, locking out alternatives in what plaintiffs claimed was an effort to illegally preserve a monopoly.

The legal battle — filed as In re: Xyrem (sodium oxybate) Antitrust Litigation, case number 3:20-md-02966 — is being handled in the U.S. District Court for the Northern District of California under Judge Richard Seeborg.

Class Action Landscape Shifts as Players Exit the Stage

Back in May 2023, Judge Seeborg certified the class and gave the green light to settlements involving Amneal Pharmaceuticals LLC and Lupin Pharmaceuticals Inc., who collectively agreed to pay $3.4 million to bow out. That left Jazz and Hikma standing alone in the litigation crosshairs — until this week.

Jazz’s decision to settle follows reports of a Zoom hearing last month, during which Jazz and a certified insurer class revealed they’d reached a settlement-in-principle. However, Hikma, along with opt-out plaintiffs like Humana Inc. and Molina Healthcare Inc., remain active players in the legal fray.

Trial Trajectory: One Path Clears, Another Looms

Judge Seeborg on Tuesday clarified the direction of the case, stating that the looming May 19 trial would proceed only between the class and Hikma, given Jazz’s exit and unresolved claims by the opt-out insurers.

"The structure of that trial is presently uncertain," he noted, emphasizing the court's desire to avoid confusion and prejudice that could arise from blending multiple plaintiff groups. He underscored that evidence from opt-out plaintiffs — aimed at proving Jazz’s alleged monopoly — would only cloud the jury’s understanding.

"Ultimately, less is more," Seeborg wrote in his order, favoring a "streamlined, relatively simpler trial" that allows each party their day in court without entangling overlapping claims.

Legal Armies Assembled: Counsel in the Spotlight

This heavyweight litigation has drawn a who’s who of legal talent:

  • The class is represented by attorneys from Girard Sharp LLP and Motley Rice LLC.

  • Opt-out insurers such as Humana, UnitedHealthcare, and Blue Cross Blue Shield of Florida are represented by Schneider Wallace, Lowey Dannenberg, Boies Schiller Flexner LLP, and Zelle LLP.

  • Jazz Pharmaceuticals has enlisted Skaggs Faucette LLP and Williams & Connolly LLP.

  • Hikma Pharmaceuticals is defended by White & Case LLP.

The Big Picture: Monopoly Allegations Cast Long Shadows

The lawsuit has spotlighted long-standing concerns around "pay-for-delay" settlements, which critics argue hinder access to affordable generics and inflate drug prices. Xyrem, a blockbuster treatment for narcolepsy, has been at the center of these concerns due to its high cost and limited competition.

While Jazz exits stage left with a hefty price tag, the remaining players prepare for a courtroom showdown that could further reshape how the pharmaceutical industry navigates the thin line between patent protection and market manipulation.

One thing is certain: the drama over Xyrem is far from its final act.

Previous Article

Zozo to Acquire Lyst in $154M Deal

Read More
4594 Posts

Rihem Akkouche

Rihem Akkouche is a passionate journalist dedicated to shedding light on compelling stories, sparking conversations, and fostering a more informed world.

Discussion

No comments yet. Be the first to join the discussion!

Don’t Miss It
America November 20, 2026 Anthropic Stock Slides After Record-Breaking IPO By – Jackie Allen
Breaking News November 20, 2026
Seven Straight Days of Red: The…

Chip stocks crashed in Asia, Europe sold off and Anthropic…

By – Derek Johnson
America November 20, 2026
How One Hat Killed America’s Favorite…

Fiona, the Cincinnati Zoo hippo born six weeks premature in…

By – Derek Johnson
America November 19, 2026
Technology Disruption Hits Major Banks, Microsoft…

NEW YORK — A wave of technology disruption has affected…

By – Jackie Allen
America November 19, 2026
No CyberAttack: FAA Lifts Nationwide Ground…

The Federal Aviation Administration (FAA) has lifted a nationwide ground…

By – Jackie Allen
USA Herald November 19, 2026
Rosa Leyva Murder: Oregon Man Believed…

OREGON CITY, Ore. — Rosa Leyva, 61, was fatally shot…

By – Jackie Allen
America November 19, 2026
Dallas Police Department Faces Federal Lawsuit…

 The Dallas Police Department is facing renewed scrutiny following a…

By – Jackie Allen
America November 19, 2026
New Hampshire Auto, Home Insurance Reductions:…

In a year when many bills only move one direction,…

By – Tyler Brooks
America November 19, 2026
GTA VI launch spotlights systemic cyber…

The GTA VI insurance risks are not about the game…

By – Tyler Brooks
America November 19, 2026
Walmart raises its outlook for the…

Walmart raises outlook for the third time this year, but…

By – Rachel Moore
America November 19, 2026
Bed bugs force FEMA staff to…

The FEMA bed bugs story adds an unlikely twist to…

By – Rachel Moore
America November 19, 2026
Anthropic shares jump 21% after $107.3B…

The Anthropic $107.3B IPO opened with a bang on Thursday.…

By – Rachel Moore
America November 19, 2026
Binance Wins $6.5B Freezing Order Over…

The Binance $6.5B freezing order may be the biggest legal…

By – Rachel Moore
America November 19, 2026
Polaris $1M Data Privacy Settlements: California…

The Polaris $1M data privacy settlements show what happens when…

By – Rachel Moore
America November 19, 2026
 Anti-Death-Penalty Groups Intensify Fight Against Capital…

  The United States recorded 37 executions in 2026 as…

By – Jackie Allen
America November 19, 2026
43 Soldiers Unlock a GTA 6…

FORT STEWART, Ga. — The 9th Brigade Engineer Battalion offered…

By – Michallie K Harrison
America November 19, 2026
Palmer Luckey Warns AI Hackers Are…

NEW YORK — Palmer Luckey says artificial intelligence is giving…

By – Michallie K Harrison
America November 19, 2026
Iowa Schools Cancel Classes as Army…

MIDDLETOWN, Iowa — Schools in southeast Iowa have canceled Friday…

By – Michallie K Harrison
America November 18, 2026
Government Investigators Find AI Platforms Generated…

Federal investigators found that four major artificial intelligence platforms could…

By – Jackie Allen
Breaking News November 19, 2026
Anthropic Hits the Nasdaq Today as…

Anthropic begins trading as “ANT” on the Nasdaq after selling…

By – Derek Johnson
America November 18, 2026
Yellowstone’ Star Luke Grimes Opens Up…

Key Takeaways Luke Grimes admits he was worried about continuing…

By – Jackie Allen
America November 18, 2026
Florida Flood Threat: Record Downpours Swamp…

The Florida flood threat turned real overnight. Torrential rainfall and…

By – Tyler Brooks
America November 18, 2026
Is GTA 6 Out? Rockstar’s Blockbuster…

Is GTA 6 out? The answer depends on where you…

By – Tyler Brooks
Business November 18, 2026
GTA VI Is Finally Here: Rockstar’s…

Grand Theft Auto VI began rolling out at midnight in…

By – Derek Johnson
America November 18, 2026
Iran Says It Targeted Kuwaiti Air…

Iran’s military said it targeted Ali Al Salem Air Base…

By – Michallie K Harrison
America November 18, 2026
13 U.S. Babies Born With Measles…

U.S. officials documented 13 babies born with measles and 112…

By – Michallie K Harrison
America November 17, 2026
Katie Couric Reveals  Memory-Loss Episode That…

Katie Couric is opening up about a recent frightening medical…

By – Jackie Allen
America November 15, 2026
Hackers Hit America’s Drinking Water Systems…

ATLANTA – Hackers have crossed a dangerous line in America’s…

By – Samuel Lopez
America November 15, 2026
America Loses Its Measles-Free Status for…

PAHO says the U.S. no longer meets the standard for…

By – Derek Johnson
America November 11, 2026
Brooklyn Building Collapse Kills 2 as…

A Brooklyn building collapse killed at least two people and…

By – Michallie K Harrison
America November 11, 2026
A Veterans Day Betrayal: House Advances…

OPINION | The Republican-led House marked Veterans Day by advancing…

By – Michallie K Harrison
America November 17, 2026
Content Creator Chrisean Rock Faces Looming…

By Samuel Lopez – USA Herald INGLEWOOD, Calif. – What…

By – Samuel Lopez
America November 15, 2026
Tower Hill Investment in Gator Athletics:…

The Tower Hill investment in Gator Athletics just rewrote the…

By – Tyler Brooks
America November 14, 2026
Golden State Valkyries Star Gabby Williams…

 Golden State Valkyries forward Gabby Williams believes Indiana Fever star…

By – Jackie Allen
America November 8, 2026
Dana White Reportedly Declines Trump White…

By Samuel Lopez – USA Herald | November 8, 2026…

By – Samuel Lopez
America November 7, 2026
Mike Tyson And Ric Flair Score…

Inside the $50 Million Legal Battle A federal judge rejected…

By – Samuel Lopez
America November 5, 2026
Dallas Cowboys Face  Crisis After Crushing…

By Jackie Allen | USA Herald The Dallas Cowboys are…

By – Jackie Allen

No posts found.

No posts found.

Signup for the USA Herald
exclusive Newsletter